EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gamma‐glutamyl transferase: A potential biomarker for pancreas steatosis in patients with concurrent obesity, insulin resistance and metabolic dysfunction‐associated steatotic liver disease

Chileka Chiyanika iD, Elizabeth Shumbayawonda, Michele Pansini, Kin Hung Liu, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Winnie Chiu Wing Chu iD

Clinical Obesity · 2025

DOI: 10.1111/cob.12712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Obesity, 2025. Verfasst von Chileka Chiyanika und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China. Hauptthemen laut MEDLINE: gamma-Glutamyltransferase, Insulin Resistance, Biomarkers, Obesity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese University of Hong Kong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To evaluate the relationship between serum gamma‐glutamyl transferase (GGT) levels and fatty pancreas in subjects with concurrent obesity, insulin resistance and metabolic dysfunction‐associated steatotic liver disease (MASLD) without a history of pancreatitis. From March 2019 to September 2021, 31 adult subjects with concurrent obesity and MASLD were recruited as part of the study investigating the biological impact of bariatric surgery and lifestyle modification on obesity. Chemical shift encoded MRI of the abdomen, LiverMultiScan, anthropometric, clinical and blood biochemistry analyses were performed prior to any intervention at baseline. GGT ( p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

gamma-GlutamyltransferaseInsulin ResistanceBiomarkersObesityMetabolic SyndromeHumansMaleFemaleMiddle AgedAdultFatty LiverPancreasPancreatic Diseases

Stichwörter der Autor:innen

fatty pancreasgamma‐glutamyl transferaseinsulin resistancemetabolic dysfunction‐associated steatotic liver diseasemetabolic syndromeobesity

Substanzen

gamma-GlutamyltransferaseBiomarkers

Autor:innen und Institutionen

  • Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.
  • Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
  • Translational Science, Perspectum Diagnostic limited, Oxford, UK.
  • Clinica Di Radiologia EOC, Istituto Di Imaging Della Svizzera Italiana (IIMSI), Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong, China.

ORCID-Profile: Chileka Chiyanika, Winnie Chiu Wing Chu

Förderung

  • Chinese University of Hong Kong

Zitieren

APA

Chiyanika, C., Shumbayawonda, E., Pansini, M., Liu, K. H., Yip, T. C., Wong, V. W., & Chu, W. C. W. (2025). Gamma‐glutamyl transferase: A potential biomarker for pancreas steatosis in patients with concurrent obesity, insulin resistance and metabolic dysfunction‐associated steatotic liver disease. Clinical Obesity. https://doi.org/10.1111/cob.12712

Vancouver

Chiyanika C, Shumbayawonda E, Pansini M, Liu KH, Yip TC, Wong VW, et al. Gamma‐glutamyl transferase: A potential biomarker for pancreas steatosis in patients with concurrent obesity, insulin resistance and metabolic dysfunction‐associated steatotic liver disease. Clinical Obesity. 2025. doi:10.1111/cob.12712

BibTeX
@article{Chiyanika2025,
  author = {Chiyanika, Chileka and Shumbayawonda, Elizabeth and Pansini, Michele and Liu, Kin Hung and Yip, Terry Cheuk-Fung and Wong, Vincent Wai-Sun and Chu, Winnie Chiu Wing},
  title = {Gamma‐glutamyl transferase: A potential biomarker for pancreas steatosis in patients with concurrent obesity, insulin resistance and metabolic dysfunction‐associated steatotic liver disease},
  journal = {Clinical Obesity},
  year = {2025},
  doi = {10.1111/cob.12712}
}
Kostenlos starten →